EUVIMEDEUVIMED entdecken
Crossref

Incidence of infections during the application of high-dose chemotherapy with autologous stem cell transplantation

Milica Milošević, Jelena Bila, Dejana Stanisavljević, Milena Todorović-Balint

Srpski medicinski casopis Lekarske komore · 2021

DOI: 10.5937/smclk2-32531 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Srpski medicinski casopis Lekarske komore, 2021. Verfasst von Milica Milošević und 3 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Autologous stem cell transplantation (AHSCT) is a well-established therapy for hematologic malignancies. Changes in transplantation strategies and improvement in supportive care have significantly altered the incidence and pattern of infections in these patients.

Aim

Evaluating the frequency of infections in the first 30 days after AHSCT, as well as the possible influence of the number of CD34 + stem cells in the graft and of the engraftment parameters: ALC500_20 (absolute lymphocyte count 0.5x109 / L per day + 20), ANC500_11 (absolute neutrophil count 0.5x109 / L per day + 11), and PLT20_13 (platelets 20x109 / L per day + 13), on the occurrence of infections. Materials and methods: The retrospective cohort study examined 80 patients above the age of 20 years, diagnosed with multiple myeloma (MM), non-Hodgkin's (NHL) or Hodgkin's lymphoma (HL), treated at the Clinic for Hematology of the Clinical Center of Serbia, in the period between July 2006 and December 2017. All episodes of fever and/or documented infection during neutropenia have been reported.

Results

The average survival after AHSCT was 34.5 months. A total of 54 patients (67.5%) had a documented infection. Gram-positive infections were five times more common than gram-negative. In gram-positive isolates, coagulase-negative staphylococcus - CoNS was the most common (37.0%) pathogen, followed by Streptococcus a haemolyticus (12.4%). Among gram-negative isolates, Escherichia coli was present in 62.5% of the cases, while Klebsiellaspp. and Ralstonia pickettii were represented with an equal frequency of 12.5%. Fungal infections were rare (Candida spp., 10.0%). Viral infections were verified in 5 (6.3%) patients (Herpes zoster virus 3.8% and H1N1 2.5%).

Conclusion

The number of CD34+ stem cells in the graft, as well as the rate of hematopoietic reconstitution, i.e., the achievement of ALC500_20, ANC500_11, and PLT20_13, were not statistically significant for the development of infections in the early phase after AHSCT.

Zitieren

APA

Milošević, M., Bila, J., Stanisavljević, D., & Todorović-Balint, M. (2021). Incidence of infections during the application of high-dose chemotherapy with autologous stem cell transplantation. Srpski medicinski casopis Lekarske komore. https://doi.org/10.5937/smclk2-32531

Vancouver

Milošević M, Bila J, Stanisavljević D, Todorović-Balint M. Incidence of infections during the application of high-dose chemotherapy with autologous stem cell transplantation. Srpski medicinski casopis Lekarske komore. 2021. doi:10.5937/smclk2-32531

BibTeX
@article{Miloevi2021,
  author = {Milošević, Milica and Bila, Jelena and Stanisavljević, Dejana and Todorović-Balint, Milena},
  title = {Incidence of infections during the application of high-dose chemotherapy with autologous stem cell transplantation},
  journal = {Srpski medicinski casopis Lekarske komore},
  year = {2021},
  doi = {10.5937/smclk2-32531}
}
Kostenlos starten →